IMPs (including placebos) are required to be labelled for ‘use in clinical trials’.  Labelling of an IMP is intended to ensure protection of the participant and traceability, enable identification of the product and trial and facilitate proper use of the investigational medicinal product.

Our company, which provides end-to-end service in clinical research, works with companies specialized in its field for labeling service.

According to Turkish Regulations, the labeling process should be performed according to GMP guideline. According to GMP guideline, the depot that carry out the labeling process can not do the labelling without GMP certificate. We have GMP licensed vendors thus we can perform labeling via our qualified vendors.